IFNG and neoplasm: By utilizing a pathological Gradient Boosting Machine (GBM) model, this study aims to explore the correlation between PS and IFNG expression, and to validate their consistency in predicting prognosis, providing a novel tool for assessing tumor immunity and aiding in personalized treatment planning.